BrainsWay Ltd.

Equities

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 07:24:09 2024-04-25 am EDT			5-day change	1st Jan Change
954.3 ^ILa	-1.91%		-0.59%	-16.95%

Apr. 17	Brainsway Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates	CI
Apr. 04	BrainsWay Ltd. Announces Publish Review Results Highlighting Potential of Deep Transcranial Magnetic Stimulation (Deep TMS?) as a Novel Therapeutic Approach for Parkinson's Disease	CI

BrainsWay Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023

March 06, 2024 at 07:30 am EST

BrainsWay Ltd. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 9.03 million compared to USD 6.03 million a year ago. Net income was USD 0.127 million compared to net loss of USD 3.87 million a year ago.

Latest news about BrainsWay Ltd.

Brainsway Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates	Apr. 17	CI
BrainsWay Ltd. Announces Publish Review Results Highlighting Potential of Deep Transcranial Magnetic Stimulation (Deep TMS?) as a Novel Therapeutic Approach for Parkinson's Disease	Apr. 04	CI
Brainsway Announces Positive Results in Late-Life Depression Post-Marketing Analysis	Mar. 28	CI
BrainsWay Ltd. Broadens Partnership with Katie?s Way Plus Through Order of an Additional 18 Deep TMS? Systems	Mar. 18	CI
Transcript : BrainsWay Ltd., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
BrainsWay Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
BrainsWay Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06	CI
Brainsway Ltd. Provides Earnings Guidance for Full Year 2024	Mar. 06	CI
BrainsWay Ltd. Announces New Rotational Field Technology in Two New Feasibility Studies	Jan. 10	CI
Brainsway Expands Deep Transcranial Magnetic Stimulation Technology in South Korea	Dec. 07	MT
BrainsWay Ltd. Announces Continued Expansion of Deep TMS in South Korea	Dec. 07	CI
Brainsway Says Blue Cross Blue Shield of Louisiana Expands Access to Mental-Health Technology	Nov. 20	MT
Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating	Nov. 16	MT
Raymond James Downgrades Brainsway to Market Perform From Outperform	Nov. 16	MT
Transcript : BrainsWay Ltd., Q3 2023 Earnings Call, Nov 15, 2023	Nov. 15
Earnings Flash (BWAY) BRAINSWAY Reports Q3 Revenue $8.3M	Nov. 15	MT
BrainsWay Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15	CI
BrainsWay Ltd. Announces Publishes the First Coverage Recommendations for Smoking Addiction Treatment Using TMS	Nov. 02	CI
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression	23-10-16	CI
Brainsway Receives 10 Orders for Deep Transcranial Magnetic Stimulation	23-09-20	MT
BrainsWay Ltd. Broadens Access to Deep TMS for U.S. Military Service Members Through Expanded Partnership with Katie's Way Plus	23-09-20	CI
ADRs Advance, Brainsway Ltd. Climbs 14.0%	23-09-14	DJ
Brainsway Ltd. Forges Strategic Partnership with Treatment Provider in Northeast U.S	23-09-05	CI
SaverOne 2014 Names Omri Hagai Finance Chief	23-08-24	MT
BrainsWay Ltd. Expands Access to Deep TMS in Asia Pacific Region	23-08-23	CI

Chart BrainsWay Ltd.

Duration

Period

More charts

Company Profile

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-07 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BRAINSWAY LTD.	-16.95%	83.26M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology